Home | Welcome to Contract Pharma   
Last Updated Wednesday, March 4 2015

Print RSS Feed

Breaking News

December 17, 2014
To develop and commercialize Janssen products with ENHANZE technology  Read More »
December 16, 2014
To focus on commercial manufacturing for solid dosage products  Read More »
December 16, 2014
Richards to support increased demand for manufacturing services  Read More »
December 16, 2014
To employ ERT’s patient safety and efficacy endpoint data collection solutions  Read More »
December 16, 2014
License agreement includes foam vehicle for Azelaic Acid   Read More »
December 16, 2014
Saunders will continue to lead the global company as president and CEO  Read More »
December 16, 2014
CMC will provide process development and GMP manufacture of OS2966  Read More »
December 15, 2014
Broadens access to key biotech hubs  Read More »
December 15, 2014
Aims to develop and commercialize long-acting hGH-CTP for growth hormone deficiency  Read More »
December 15, 2014
Includes Czech production facility and assets for H5N1, H1N1 and seasonal flu vaccines  Read More »
December 12, 2014
Ravalli to oversee NJ ops  Read More »
December 11, 2014
Offers new manufacturing options and additional filling capacity  Read More »
December 11, 2014
X-Chem to identify drug candidates against Alexion targets  Read More »
December 10, 2014
Dr. Gerberding responsible for global public policy and corporate responsibility  Read More »
December 10, 2014
Phase I study will evaluate Opdivo and mogamulizumab in solid tumors  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On